Skip to content
healthcare.dev

Erythromycin Ethylsuccinate

NDC 60219-1504, Erythromycin, suspension, from Amneal Pharmaceuticals NY LLC.

Product NDC
60219-1504
Status
Listed
Labeler
Amneal Pharmaceuticals NY LLC
Dosage form
SUSPENSION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211204
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1504 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ERYTHROMYCIN ETHYLSUCCINATE400 mg/5mL

Pharmacologic classes

Decreased Sebaceous Gland Activity [PE]; Macrolide Antimicrobial [EPC]; Macrolide [EPC]; Macrolides [CS]

Package NDCNDC-11Package
60219-1504-260219150402100 mL in 1 BOTTLE (60219-1504-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/581d7430-1a80-42a6-befb-4c3ae8140392
  • NADAC price for package 60219150402

    GET /v1/drugs/nadac/60219150402

Use it

Look up 60219-1504 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/60219-1504 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 60219-1504. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.